Table 4.

Dose dependent therapeutic efficacy of YAP/TAZ in different hormone receptor (HR) status.

HR status	YAP/TAZ status	Therapy response
		RTDI ≤ 85%				RTDI >85%
		ORR (%)	P	pCR	P	ORR (%)	P	pCR	P
Positive	≤0.5	78.47	0.691	6/35	0.154	96.34	0.047	29/99	0.038
	>0.5	66.10		9/40		80.67		11/66
Negative	≤0.5	82.66	0.352	4/22	0.098	99.01	0.011	36/70	0.005
	>0.5	74.34		7/27		77.06		2/38